Method of generating natural killer cells and dendritic cells from human embryonic stem cell-derived hemangioblasts

Details for Australian Patent Application No. 2010326027 (hide)

Owner Stem Cell & Regenerative Medicine International, Inc.

Inventors Kimbrel, Erin; Lu, Shi-Jiang

Agent Freehills

Pub. Number AU-A-2010326027

PCT Pub. Number WO2011/068896

Priority 61/266,661 04.12.09 US

Filing date 1 December 2010

Wipo publication date 9 June 2011

International Classifications

C12N 5/078 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells from blood or from the immune system

A61K 35/12 Medicinal preparations containing material or reaction products thereof with undetermined constitution - Materials from mammals or birds

Event Publications

21 June 2012 PCT application entered the National Phase

  PCT publication WO2011/068896 Priority application(s): WO2011/068896

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010326028-Method for removing cytokines from blood with surface immobilized polysaccharides

2010326026-Surfactant-enabled transition metal-catalyzed chemistry